IL152773A0 - Oil-in-water emulsion - Google Patents

Oil-in-water emulsion

Info

Publication number
IL152773A0
IL152773A0 IL15277301A IL15277301A IL152773A0 IL 152773 A0 IL152773 A0 IL 152773A0 IL 15277301 A IL15277301 A IL 15277301A IL 15277301 A IL15277301 A IL 15277301A IL 152773 A0 IL152773 A0 IL 152773A0
Authority
IL
Israel
Prior art keywords
compositions
oil
water
water emulsion
parenteral administration
Prior art date
Application number
IL15277301A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL152773A0 publication Critical patent/IL152773A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
IL15277301A 2000-05-25 2001-05-22 Oil-in-water emulsion IL152773A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0012597.1A GB0012597D0 (en) 2000-05-25 2000-05-25 Formulation
PCT/GB2001/002259 WO2001089474A2 (en) 2000-05-25 2001-05-22 O/w emulsion

Publications (1)

Publication Number Publication Date
IL152773A0 true IL152773A0 (en) 2003-06-24

Family

ID=9892262

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15277301A IL152773A0 (en) 2000-05-25 2001-05-22 Oil-in-water emulsion

Country Status (18)

Country Link
US (3) US20030144356A1 (de)
EP (1) EP1289503B1 (de)
JP (1) JP2003535057A (de)
KR (1) KR20030009501A (de)
CN (1) CN1430503A (de)
AT (1) ATE365538T1 (de)
AU (2) AU5858801A (de)
BR (1) BR0111136A (de)
CA (1) CA2407764A1 (de)
DE (1) DE60129134T2 (de)
ES (1) ES2287128T3 (de)
GB (1) GB0012597D0 (de)
IL (1) IL152773A0 (de)
MX (1) MXPA02011532A (de)
NO (1) NO20025629L (de)
NZ (1) NZ522365A (de)
WO (1) WO2001089474A2 (de)
ZA (1) ZA200208853B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1166368C (zh) * 2003-02-26 2004-09-15 刘威 海狗油脂肪乳注射液、其制备方法及其在制备静脉注射剂中的应用
US7780873B2 (en) * 2004-02-23 2010-08-24 Texas A&M University System Bioactive complexes compositions and methods of use thereof
CA2572344A1 (en) * 2004-07-01 2006-01-19 Schepens Eye Research Compositions and methods for treating eye disorders and conditions
CN100358513C (zh) * 2005-04-07 2008-01-02 常州市第四制药厂有限公司 一种丙泊酚注射液的制备工艺
AU2006310113A1 (en) * 2005-08-05 2007-05-10 Bharat Serums & Vaccines Ltd. Intravenous propofol emulsion compositions having preservative efficacy
WO2007059431A1 (en) * 2005-11-14 2007-05-24 The Trustees Of Columbia University In The City Of New York Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs
WO2008036353A2 (en) * 2006-09-19 2008-03-27 The Trustees Of Columbia University In The City Of New York Omega-3 diglyceride emulsions
CN101411685B (zh) * 2007-10-19 2011-04-20 上海医药工业研究院 一种静脉麻醉药2,6-二异丙基苯酚微乳组合物及其制备方法
US20110071090A1 (en) * 2009-03-11 2011-03-24 Stable Solutions Llc Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
US8241672B2 (en) * 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US9034389B2 (en) * 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
WO2010141648A2 (en) 2009-06-05 2010-12-09 Allergan, Inc. Artificial tears and therapeutic uses
US20110086914A1 (en) * 2009-10-13 2011-04-14 Bailes Julian E Methods for Treating Traumatic Brain Injury
US20110200644A1 (en) * 2010-02-18 2011-08-18 Martek Biosciences Corporation DHA Ester Emulsions
WO2011103514A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha triglyceride emulsions
WO2011103512A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha free fatty acid emulsions
EP2560633B8 (de) * 2010-04-23 2020-08-12 The Government of the United States, as represented by The Secretary of the Army Intravenöse omega-3-fettsäuren-zusammensetzungen sowie verwendungsverfahren dafür
US11236351B2 (en) 2010-05-17 2022-02-01 Dow Agrosciences Llc Production of DHA and other LC PUFAs in plants
JP2013526605A (ja) * 2010-05-25 2013-06-24 エリック カーツ， 脂肪酸の安定な処方物
AU2011276236B2 (en) * 2010-07-06 2016-03-10 Glaxosmithkline Biologicals S.A. Cationic oil-in-water emulsions
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
EA022849B1 (ru) 2010-10-12 2016-03-31 Дзе Медсинз Компани Эмульсионные композиции клевидипина, содержащие противомикробные агенты
US20120251685A1 (en) * 2011-04-04 2012-10-04 Martek Biosciences Corporation Oil-in-Water Emulsions Comprising a Polyunsaturated Fatty Acid and Methods of Making the Same
US10052352B2 (en) 2011-06-15 2018-08-21 Stable Solutions Llc Therapeutic application of parenteral krill oil
RS56394B1 (sr) * 2011-06-15 2017-12-29 Stable Solutions Llc Terapeutska primena parenteralnog kril ulja
TW201307553A (zh) * 2011-07-26 2013-02-16 Dow Agrosciences Llc 在植物中生產二十二碳六烯酸（ｄｈａ）及其他長鏈多元不飽和脂肪酸（ｌｃ－ｐｕｆａ）之技術
CN102366404B (zh) * 2011-10-20 2015-10-07 四川百利药业有限责任公司 一种丙泊酚中/长链脂肪乳剂
EP2884964A4 (de) * 2012-08-16 2016-01-06 Emcure Pharmaceuticals Ltd Pharmazeutische zusammensetzung von propofol
US10070643B2 (en) 2013-03-28 2018-09-11 The Trustees Of Columbia University In The City Of New York Reperfusion with omega-3 glycerides promotes donor organ protection for transplantation
ES2607715B1 (es) * 2015-10-01 2018-01-17 Solutex Na, Lcc Proceso para la preparación y estabilización de emulsiones con omega-3 mediante redes cristalinas isométricas de derivados de celulosa

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637404A (en) * 1992-01-31 1997-06-10 Aluminum Company Of America Reflective aluminum strip
US5478414A (en) * 1992-01-31 1995-12-26 Aluminum Company Of America Reflective aluminum strip, protected with fluoropolymer coating and a laminate of the strip with a thermoplastic polymer
EE03220B1 (et) * 1994-02-04 1999-10-15 Scotia Lipidteknik Ab Õli-vees-emulsioon, selle kasutamine ja seda sisaldav farmatseutiline kompositsioon
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
CA2338703C (en) * 1998-08-19 2009-03-24 Rtp Pharma Inc. Injectable aqueous dispersions of propofol
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6582723B2 (en) * 2001-05-03 2003-06-24 Wayne F. Gorsek Cancer immune composition for prevention and treatment of individuals

Also Published As

Publication number Publication date
CN1430503A (zh) 2003-07-16
NO20025629L (no) 2003-01-08
MXPA02011532A (es) 2003-04-25
NO20025629D0 (no) 2002-11-22
WO2001089474A2 (en) 2001-11-29
GB0012597D0 (en) 2000-07-12
CA2407764A1 (en) 2001-11-29
KR20030009501A (ko) 2003-01-29
US20030144356A1 (en) 2003-07-31
WO2001089474A3 (en) 2002-03-07
DE60129134D1 (en) 2007-08-09
BR0111136A (pt) 2003-04-08
AU5858801A (en) 2001-12-03
ZA200208853B (en) 2004-02-19
JP2003535057A (ja) 2003-11-25
AU2001258588B2 (en) 2005-05-19
US20080312338A1 (en) 2008-12-18
DE60129134T2 (de) 2008-02-28
ATE365538T1 (de) 2007-07-15
ES2287128T3 (es) 2007-12-16
EP1289503A2 (de) 2003-03-12
EP1289503B1 (de) 2007-06-27
US20060257433A1 (en) 2006-11-16
NZ522365A (en) 2004-09-24

Similar Documents

Publication Publication Date Title
DE60129134D1 (en) O/w emulsion
EA200601460A1 (ru) Препарат микроэмульсии с высокой концентрацией пропофола для анестезирующих применений
EE200300109A (et) Protsess vedela emulsioonkompositsiooni valmistamiseks ja emulsiooni kontsentraadi valmistamiseks, farmatseutiline kompositsioon, emulsiooni kontsentraat, komplekt ja emulsioonkompositsioon
IL114212A0 (en) Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
EP1039893A4 (de) Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen
KR870002834A (ko) 유제조성물의 제조방법
DK1238677T3 (da) Parenterale fedtemulsioner, der omfatter edetat som konserveringsmiddel
JP2003535057A5 (de)
KR870002835A (ko) 이온화성 소수성약제의 약제학적 제조방법
BR0111016A (pt) Composições farmacêuticas de liberação sustentada para a administração parenteral de compostos hidrófilos biologicamente ativos
MA26922A1 (fr) Procede de preparation d'une composition
DK1158959T3 (da) Sammensætninger og fremgangsmåder til forbedret indgift af hydrofobe terapeutiske midler
DE60323953D1 (de) Verfahren zur herstellung einer fein selbstemulgierbaren pharmazeutischen zusammensetzung
DE69422818D1 (de) Neue emulsionsformulierung
EA200300047A1 (ru) Прозрачное водное анестезирующее средство
EA200301019A1 (ru) Доставляемая перорально фармацевтическая композиция, включающая препарат с низкой растворимостью в воде (ингибитор cox-2), растворитель, жирную кислоту и органический амин
MY137749A (en) New self emulsifying drug delivery system
MY140556A (en) Clear pharmaceutical aqueous microemulsion comprising propofol and process for preparation
BR0009214A (pt) Composições aquosas estáveis contendo umcomposto de silìcio
MXPA02011531A (es) Beneficio de superviviencia.
RU96110661A (ru) Линимент растворимого стрептоцида 5%-ного